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nal of Thoracic and Cardiovascular Surgery evaluates the
role of a noninvasive single-photon emission tomography/
x-ray computed tomography (SPECT/CT) imaging method
to quantify the matrix metalloproteinase (MMP) activity in
tissue-engineered vascular grafts remodeling after implanta-
tion in a growing animalmodel. Stacy and colleagues1 clearly
demonstrate the feasibility of this innovative imagingmethod
to assess MMP activity and conclude that such activity re-
mains elevated in tissue-engineered grafts 6 months after im-
plantation, which may indicate remodeling.
Many articles have demonstrated promising results of the
application of the concept of tissue-engineering to the surgery
of congenital cardiac defects, as such tissue-engineered de-
vices (patches, grafts, valves, or valved tubes) undergo a bio-
logic remodeling and display a growth potential, which is
essential to this specific population. Nevertheless, little is still
known about the exact mechanisms of this complex in vivo
remodeling and the factors that could influence the quality
of the biologic steps allowing a beneficial and sustainable
transition of a cell-seeded (or not) polymeric (or biologic)
scaffold to an autologous, living, and growing new anatomic
structure (such as a vessel or a valve). This justifies and em-
phasizes the need for studies such as this article, which comes
from the group of Breuer and Shinoka that has been now
working successfully on that exciting topic for many years.
On the basis of voluminous evidence that MMPs
(especially MMP-2 and MMP-9) may play a role in the
remodeling of tissue-engineered vascular grafts, Stacy and
colleagues1 demonstrates the utility of a noninvasivemethod
of imaging (SPECT/CT) in assessing a biologic activity that
seems to be related to the remodeling occurring in these
vascular devices. Imaging revealed higher MMP activity
in grafts than in native tissue and in unseeded than in seeded
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remodeling process in a noninvasive way. Indeed, this type
ofmolecular imaging (or any other type, actually)may assist
the surgical and scientific community in making progress in
the clinical application of tissue engineering by allowing a
serial assessment of remodeling in tissue-engineered
devices (even beyond the field of pediatric cardiac surgery).
This study has some limitations, including the small
number of animal implantations and the absence of a pre-
cise biologic explanation of why unseeded scaffolds have
a higher MMP activity. Indeed, the marker that was used
in this study identifies a large group of MMPs that are
different from each other in biologic roles, explaining
why Stacy and colleagues1 cannot determine the role of
those MMPs specifically involved in the vascular remodel-
ing. Moreover, this SPECT/CT imaging reflects the MMP
activity without reflecting the activity of MMP inhibitors;
such an incomplete picture is of limited interest because it
is the coupling of MMP and inhibitor (and not MMP alone)
that determines the biologic effects in terms of extracellular
matrix deposition and remodeling. Finally, Stacy and
colleagues1 do not demonstrate in this article a direct corre-
lation between MMP activity observed with SPECT/CT
imaging on the one hand and immunohistochemical evi-
dence of vascular remodeling on the other hand. This study
thus is unable to validate fully this noninvasive molecular
imaging method as a true marker of biologic remodeling.
Future studies (which will need a larger number of animal
implantations to meet a better statistical power) should
definitely focus on the demonstration of such a direct
correlation between molecular imaging and histopathology.
Despite these limitations, the article of Stacy and
colleagues1 is definitely of major interest, especially for
the new generation of cardiothoracic surgeons who will
probably have the routine opportunity to implant tissue-
engineered devices in patients.
To conclude, I believe that the main merit of this article is
to emphasize the need for new tools (especially noninvasive
tools because of their clinical application) to provide a
better understanding of the biologic in vivo remodeling of
tissue-engineered devices after implantation, which is an
indispensable step in the promotion of regenerative therapy.Reference
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